Results

Total Results: 783 records

Showing results for "therapy".

1. Archived: Comparative Effectiveness of Antiviral Treatment for Hepatitis C Virus Infection in Adults: A Systematic Review: Hepatitis C: Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/comparative-effectiveness-of-antiviral-treatment-for-hepatitis-c-virus-infection-in-adults-a-systematic-review/hepatitis-c-screening-2013
   November 15, 2012 - For regimens longer than 12 weeks, dual therapy was continued to the end of treatment. … Harms of Antiviral Treatments Six head-to-head trials of dual therapy with pegylated interferon alfa … more effective treatments. … in part on the effectiveness of available treatments 81 . … hepatocellular carcinoma, liver transplantation rates, and quality of life) and harms of antiviral therapies

2. Task Force Issues Final Recommendation Statement on Hormone Therapy for Preventing Chronic Conditions in Postmenopausal People (pdf file)
   www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/hormone-therapy-postmenopause-final-rec-bulletin.pdf
   November 01, 2022 - Task Force Issues Final Recommendation Statement on Hormone Therapy for Preventing Chronic Conditions … www.uspreventiveservicestaskforce.org Task Force Issues Final Recommendation Statement on Hormone Therapy … for Preventing Chronic Conditions in Postmenopausal People Hormone therapy should not be used by … Hormone therapy refers to the use of medication that contains female hormones, which naturally become … While hormone therapy may reduce the risk of some conditions, it also can lead to serious harms.

3. Comparative Effectiveness of Antiviral Treatment for Hepatitis C Virus Infection in Adults: A Systematic Review (pdf file)
   www.uspreventiveservicestaskforce.org/home/getfilebytoken/o6pGCffkVCx24mNebJGCXg
   January 01, 2013 - For regimens longer than 12 weeks, dual therapy was continued to the end of treatment. … Harms of Antiviral Treatments Six head-to-head trials of dual therapy with pegylated interferon alfa … identify more effective treatments. … in part on the effectiveness of available treatments (81). … hepatocellular carcinoma, liver transplantation rates, and quality of life) and harms of antiviral therapies

4. Evidence Summary: Hepatitis B Virus Infection in Adolescents and Adults: Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/hepatitis-b-virus-infection-screening
   December 15, 2020 - Based on 18 trials (n = 2972), antiviral therapy compared with placebo or no treatment was associated … therapies to achieve intermediate outcomes. … Antiviral Therapy vs Placebo or No Treatment Eighteen trials (n = 2972) reported effects of antiviral … Antiviral Therapy vs Placebo or No Treatment Seven randomized trials of antiviral therapy vs placebo … Antiviral Therapy vs Placebo or No Treatment There were no statistically significant differences between

5. Final Evidence Summary: Hepatitis C Virus Infection in Adolescents and Adults: Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/hepatitis-c-screening
   March 02, 2020 - USPSTF review on HCV screening in adults 5 , 6 and a comparative effectiveness review on antiviral treatments … What is the effectiveness of currently recommended antiviral treatments in improving health outcomes … What is the effectiveness of currently recommended antiviral treatments in achieving an SVR in patients … What are the harms of currently recommended antiviral treatments? … Three studies focused on DAAs, 66 , 68 , 77 1 study evaluated interferon-based treatments and DAAs,

6. Final Research Plan: Pregnant Women: Human Immunodeficiency Virus (HIV) Infection: Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan-pregnant-women/human-immunodeficiency-virus-hiv-infection-screening
   June 15, 2017 - . †  Harms of treatment include adverse maternal and infant outcomes associated with use of antiretroviral … therapy. … treatment interruption Comparisons KQs 1, 3: HIV screening vs. no screening KQ 2: Repeat … the USPSTF revised the analytic framework to differentiate the harms of screening from the harms of treatment … diagnostic staging step, and clarify that the evidence review will focus on the benefits and harms of treatment

7. Archived: Screening for HIV in Pregnant Women: Evidence Summary: Human Immunodeficiency Virus (HIV) Infection: Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/screening-for-hiv-in-pregnant-women-evidence-summary/human-immunodeficiency-virus-hiv-infection-screening-2013
   November 15, 2012 - , with the widespread adoption of routine prenatal screening coupled with the use of more effective therapies … breastfeeding populations, because these may provide some information about the effectiveness of antiretroviral therapies … without treatment. … or treatment 22 , 23 , 25 . … in the United States and other developed countries, except for randomized trials of antiretroviral therapies

8. Draft Research Plan: Human Immunodeficiency Virus (HIV): Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/human-immunodeficiency-virus-hiv-infection-pregnant-nonpregnant-adults
   November 30, 2023 - . † Harms of treatment include adverse effects associated with antiretroviral therapy, including cardiometabolic … test results, anxiety and effects of labeling, and partner discord, abuse, or violence. † Harms of treatment … and adults with chronic HIV regardless of CD4 count vs. treatment based on CD4 threshold on mortality … single-drug regimens; pregnant persons who discontinued ART during pregnancy; pregnant persons with treatment … Department of Health and Human Services Panel on Treatment of HIV During Pregnancy and Prevention of

9. Screening for HIV in Pregnant Women: Systematic Review to Update the 2005 USPSTF Recommendation (pdf file)
   www.uspreventiveservicestaskforce.org/home/getfilebytoken/mTPBWPMDqfuWvodfd5R5Ms
   November 01, 2012 - update the 2005 USPSTF review, focusing on previ- ously identified research gaps and new evidence on treatments … with the widespread adoption of routine prenatal screening cou- pled with the use of more effective therapies … without treatment. … or treatment (22, 23, 25). … in the United States and other developed countries, except for randomized trials of antiretroviral therapies

10. Final Research Plan: Human Immunodeficiency Virus (HIV): Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/human-immunodeficiency-virus-hiv-infection-pregnant-nonpregnant-adults
    February 22, 2024 - . † Harms of treatment include adverse effects associated with antiretroviral therapy, including cardiometabolic … † Harms of treatment include adverse maternal and infant outcomes associated with use of antiretroviral … and adults with chronic HIV regardless of CD4 count vs. treatment based on CD4 threshold on mortality … single-drug regimens; pregnant persons who discontinued ART during pregnancy; pregnant persons with treatment … Department of Health and Human Services Panel on Treatment of HIV During Pregnancy and Prevention of

11. Final Research Plan: Nonpregnant Adolescents and Adults: Human Immunodeficiency Virus (HIV) Infection: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan-nonpregnant-adolescents-and-adults/human-immunodeficiency-virus-hiv-infection-screening
    June 15, 2017 - . †  Harms of treatment include adverse effects associated with antiretroviral therapy, including cardiometabolic … studies KQ 5: Randomized, controlled trials and controlled observational studies; will consider treatment … diagnostic staging step, and clarify that the evidence review will focus on the benefits and harms of treatment … with antiretroviral therapy. … therapy regimens."

12. Final Recommendation Statement: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/statin-use-in-adults-preventive-medication
    August 23, 2022 - underprediction in disadvantaged communities 10 , 11 that could lead to underutilization of preventive therapies … Treatment and Statin Intensity There are limited data directly comparing the effects of different statin … , 31 No study directly compared treatment with statins titrated to attain a target cholesterol level … vs fixed-dose treatment strategies. … Effect of statin treatment vs usual care on primary cardiovascular prevention among older adults: the

13. Screening for Hepatitis B Virus Infection in Nonpregnant Adolescents and Adults: Updated Evidence Report and Systematic Review for the US Preventive Service Task Force (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/TkWNoq6KQb3SoZ54gscLCQ
    July 25, 2016 - Based on 18 trials (n = 2972), antiviral therapy compared with placebo or no treatment was associated … therapies to achieve intermediate outcomes. … Antiviral Therapy vs Placebo or No Treatment Eighteen trials (n = 2972) reported effects of antiviral … Antiviral Therapy vs Placebo or No Treatment Seven randomized trials of antiviral therapy vs placebo … Antiviral Treatment vs Placebo or No Treatment on Health Outcomes Favors antiviral therapy Favors placebo

14. Evidence Summary: Pregnant Women: Human Immunodeficiency Virus (HIV) Infection: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-pregnant-women1/human-immunodeficiency-virus-hiv-infection-screening
    June 11, 2019 - Main Outcomes and Measures: Mother-to-child transmission; harms of screening and treatment; screening … declined after the widespread adoption of routine prenatal screening, coupled with the use of effective therapies … Effectiveness of Treatment Key Question 4. … Harms of Treatment Key Question 5. … Comparative safety of antiretroviral treatment regimens in pregnancy.

15. Evidence Summary: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/statin-use-in-adults-preventive-medication
    August 23, 2022 - Benefits of Statin Treatment Key Question 1a. … group, high crossover from usual care, and increased use of nonstatin therapies in the usual care group … Harms of Statin Treatment Key Question 2a. … by Treatment Intensity Key Question 3. … of secondary prevention, defined statin intensity inadequately, or included nonstatin lipid-lowering therapies

16. Screening for and Treatment of Suicide Risk Relevant to Primary Care: A Systematic Review for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/vxPM4Bo9RXZGUDH6MWnDht
    May 01, 2013 - ) Fair (other therapies) Data on suicide deaths were insufficient. … ) Fair (other therapies) No trials directly reported harms; 4 of 11 trials related to key questions … Psychosocial versus pharmacological treatments for deliberate self harm. … , with direct therapeutic contact Comtois et al, 2011 (47) 19–62 (37) 62 Other therapy, without direct … direct therapeutic contact King et al, 2009 (78) 13–17 (16) 71 Improving treatment adherence without

17. JAMA (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/GcjfCZtGpACQMv2KScLbEu
    June 11, 2019 - MAIN OUTCOMES AND MEASURES Mother-to-child transmission; harms of screening and treatment; screening … declined after the widespread adoption of routine prenatal screening, coupled with the use of effective therapies … Effectiveness of Treatment Key Question 4. … Harms of Treatment Key Question 5. … Comparative safety of antiretroviral treatment regimens in pregnancy.

18. PII: S0749-3797(01)00255-0 (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/yw_rbA_nQrCnkaN8X5t56S
    January 01, 2001 - ● What are the adverse effects of diet or drug treatment? … What are the adverse effects of diet or drug treatment? … Effectiveness of Drug Therapy Effects of drug therapy on CHD events. … Drug therapy appears to have little effect on total mortality after 5 to 7 years of treatment in lower-risk … after 5 to 10 years of treatment; the incremental benefit from beginning therapy earlier is, therefore

19. Archived: Evidence Summary: Lipid Disorders in Adults (Cholesterol, Dyslipidemia): Screening, 2001 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/lipid-disorders-in-adults-cholesterol-dyslipidemia-screening-2001
    April 09, 2001 - What are the adverse effects of diet or drug treatment? … Effectiveness of Drug Therapy Effects of drug therapy on CHD events. … Drug therapy appears to have little effect on total mortality after 5 to 7 years of treatment in lower-risk … after 5 to 10 years of treatment; the incremental benefit from beginning therapy earlier is, therefore … What are the adverse effects of diet or drug treatment?

20. Recommendation: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/statin-use-in-adults-preventive-medication
    August 23, 2022 - underprediction in disadvantaged communities 10 , 11 that could lead to underutilization of preventive therapies … , 31 No study directly compared treatment with statins titrated to attain a target cholesterol level … vs fixed-dose treatment strategies. … Trials that directly compare statin therapy titrated to target lipid levels vs fixed-dose therapy to … Effect of statin treatment vs usual care on primary cardiovascular prevention among older adults: the